Liver Function Test (LFT) Cost in India 2026: SGOT, SGPT, Bilirubin Price Guide
Liver function test price in India is a key concern for families managing the country's massive burden of liver disease — India accounts for approximately 18% of the world's hepatitis B cases, has the highest rate of Non-Alcoholic Fatty Liver Disease (NAFLD) in Asia, and sees widespread liver damage from alcohol, herbal medicines, and chronic medication use. An LFT, also called a liver panel or hepatic function panel, is the primary blood test to assess liver health, and knowing its cost and what it means can help Indian families catch liver problems before they become irreversible.
Key Facts About Liver Function Tests in India
| Parameter | Detail |
|---|---|
| Also known as | LFT, Liver Panel, Hepatic Function Panel, LFTs |
| LFT cost at private labs | ₹350 – ₹950 |
| Government hospital cost | ₹100 – ₹300 |
| Diagnostic chain cost | ₹250 – ₹650 |
| Fasting required? | Preferred (8 hours) for bilirubin accuracy |
| Result turnaround | Same day (3–5 hours) |
| CGHS approved rate | ₹200 – ₹350 |
| Hepatitis B carriers in India | ~40 million (WHO estimate) |
| NAFLD prevalence in urban India | ~30–40% of adults |
What Does an LFT Test Include?
A standard liver function test panel includes 8–12 parameters that together give a comprehensive picture of liver health:
Liver Enzymes (Markers of Liver Cell Damage)
| Test | Full Name | Normal Range (Indian Adults) | What High Levels Indicate |
|---|---|---|---|
| SGPT / ALT | Serum Glutamate Pyruvate Transaminase / Alanine Aminotransferase | Men: 7–56 IU/L; Women: 7–45 IU/L | Liver cell damage (hepatitis, fatty liver, medications) |
| SGOT / AST | Serum Glutamate Oxaloacetate Transaminase / Aspartate Aminotransferase | Men: 10–40 IU/L; Women: 9–32 IU/L | Liver or muscle damage; alcoholic hepatitis (SGOT > SGPT) |
| ALP | Alkaline Phosphatase | 44 – 147 IU/L (adults) | Bile duct obstruction, bone disease, liver metastasis |
| GGT | Gamma-Glutamyl Transferase | Men: 9–48 IU/L; Women: 7–25 IU/L | Alcohol use, bile duct disease, fatty liver |
Liver Synthetic Function (How Well the Liver Produces Proteins)
| Test | Normal Range | What Abnormal Levels Indicate |
|---|---|---|
| Serum Albumin | 3.5 – 5.0 g/dL | Low = chronic liver disease, malnutrition, kidney disease |
| Total Protein | 6.0 – 8.0 g/dL | Low = malnutrition, liver disease; high = chronic infection |
| Prothrombin Time (PT) / INR | PT: 11–13.5 seconds; INR: 0.8–1.2 | Elevated = impaired clotting (liver not making clotting factors) |
Bilirubin (Bile Pigment Markers)
| Test | Normal Range | What High Levels Indicate |
|---|---|---|
| Total Bilirubin | 0.2 – 1.2 mg/dL | Jaundice, liver disease, haemolysis |
| Direct (Conjugated) Bilirubin | 0.0 – 0.3 mg/dL | Bile duct obstruction, hepatocellular jaundice |
| Indirect (Unconjugated) Bilirubin | 0.1 – 0.8 mg/dL | Haemolytic anaemia, Gilbert's syndrome (common in India) |
Additional Liver Markers
- LDH (Lactate Dehydrogenase): Elevated in liver injury and haemolysis
- 5'-Nucleotidase: More specific than ALP for bile duct disease
LFT Test Price by City in India
| City | Govt Hospital | Private Lab | Diagnostic Chain |
|---|---|---|---|
| Mumbai | ₹100 – ₹280 | ₹400 – ₹950 | ₹280 – ₹650 |
| Delhi | ₹100 – ₹260 | ₹380 – ₹900 | ₹260 – ₹620 |
| Bangalore | ₹100 – ₹280 | ₹400 – ₹950 | ₹270 – ₹640 |
| Chennai | ₹100 – ₹260 | ₹380 – ₹900 | ₹260 – ₹620 |
| Hyderabad | ₹100 – ₹260 | ₹370 – ₹870 | ₹250 – ₹610 |
| Pune | ₹100 – ₹270 | ₹390 – ₹920 | ₹260 – ₹630 |
| Kolkata | ₹80 – ₹220 | ₹340 – ₹800 | ₹230 – ₹570 |
Prices as of March 2026. May vary by lab.
Individual SGPT/SGOT tests cost ₹80–₹200 at private labs. If your doctor needs only specific parameters, ordering individual tests can be cheaper than the full panel. Thyrocare offers a full LFT panel for approximately ₹249–₹399 when booked online with home collection.
Why Indians Need to Track Liver Health Regularly
1. Non-Alcoholic Fatty Liver Disease (NAFLD)
NAFLD — fat accumulation in the liver not caused by alcohol — affects an estimated 30–40% of urban Indian adults and is rising sharply due to obesity, diabetes, and high-carbohydrate diets. India has the highest NAFLD rate in Asia. NAFLD can progress silently through stages:
NAFLD → Non-Alcoholic Steatohepatitis (NASH) → Liver Fibrosis → Cirrhosis → Liver Cancer
An LFT showing mildly elevated SGPT (ALT) is often the first clue. Catching it early (NAFLD stage) allows complete reversal with weight loss and dietary changes — no medication needed. By cirrhosis, the damage is irreversible.
2. Hepatitis B and Hepatitis C
India has approximately 40 million chronic Hepatitis B carriers — many are unaware of their status. Hepatitis C affects an estimated 6–12 million Indians. Both viruses cause chronic liver inflammation that silently progresses to cirrhosis and liver cancer over 10–30 years.
An LFT + HBsAg (Hepatitis B surface antigen) test is the minimum annual check for anyone who:
- Has not been vaccinated against Hepatitis B
- Had a blood transfusion before 1993 (pre-screening era)
- Is a healthcare worker
- Has a family member with Hepatitis B
3. Alcohol-Related Liver Disease
India has one of the fastest-growing rates of alcohol consumption in the world. The pattern of SGOT:SGPT ratio > 2:1 strongly suggests alcoholic hepatitis. An elevated GGT is the most sensitive LFT marker for alcohol use.
4. Medication-Induced Liver Injury (DILI)
Drug-Induced Liver Injury (DILI) is common in India because of:
- Antituberculosis drugs (isoniazid, rifampicin, pyrazinamide) — LFT monitoring is mandatory during TB treatment
- Ayurvedic and herbal remedies — multiple ILBS and AIIMS studies have documented hepatotoxicity from certain herbal preparations
- Statins — mild SGPT elevation in 1–3% of patients; severe DILI rare
- Paracetamol (overdose) — most common cause of acute liver failure in India
5. Jaundice in Children
In infants and young children, elevated bilirubin is often the first sign of liver disease, biliary atresia, or haemolytic conditions. Neonatal jaundice monitoring with bilirubin levels is routine in NICU care.
Interpreting Your LFT Results: What the Patterns Mean
| LFT Pattern | Most Likely Cause |
|---|---|
| SGPT elevated, SGOT elevated (SGPT > SGOT) | Viral hepatitis, NAFLD, medications |
| SGOT elevated more than SGPT (ratio > 2:1) | Alcoholic hepatitis |
| ALP + GGT elevated, bilirubin elevated | Bile duct obstruction (gallstones, cholangitis) |
| Low albumin + elevated PT/INR | Chronic liver disease, cirrhosis |
| All enzymes elevated + elevated bilirubin | Acute hepatitis (viral, drug-induced) |
| Mildly elevated bilirubin (indirect), rest normal | Gilbert's syndrome (benign, very common in India) |
Gilbert's syndrome note: This is a benign, hereditary condition affecting up to 7–10% of Indians, where indirect bilirubin is mildly elevated (1.0–3.0 mg/dL) — often causing unnecessary concern. It is harmless and requires no treatment. Diagnosis is established when all other LFT parameters are normal and the elevation worsens with fasting or illness.
LFT During TB Treatment: A Critical Monitoring Protocol
Antituberculosis therapy (ATT) is hepatotoxic in up to 10% of Indian patients. RNTCP (Revised National Tuberculosis Control Programme) guidelines mandate:
- Baseline LFT before starting ATT
- LFT at 2 weeks after starting treatment
- LFT at monthly intervals during the intensive phase
- Stop ATT immediately if SGPT > 3× upper limit of normal with symptoms, or > 5× without symptoms
Missing LFT monitoring during TB treatment can lead to acute liver failure — a preventable tragedy.
Keep Your Liver Test Records in One Place with Ayu
After getting your liver function test, it's easy to lose track of results over time — especially during TB treatment, hepatitis B monitoring, or tracking NAFLD improvement with weight loss. Ayu's AI reads and organises your medical reports automatically.
- 📷 Scan your report with your phone — Ayu reads it in seconds
- 🗂️ Track trends — compare your SGPT, SGOT, and bilirubin levels over time in one place
- 📲 Share instantly with any doctor via QR code
- 🗣️ Works in Hindi, Marathi, Tamil and 21 other Indian languages
Frequently Asked Questions
Q: What is the difference between SGPT and SGOT?
SGPT (also called ALT — Alanine Aminotransferase) is found primarily in liver cells and is the more specific marker for liver damage. SGOT (also called AST — Aspartate Aminotransferase) is found in the liver, heart, muscle, and other tissues — making it less liver-specific. When SGPT is higher than SGOT, the cause is usually a liver problem (viral hepatitis, NAFLD). When SGOT is more than twice SGOT, alcohol-related liver disease is strongly suggested.
Q: What is a mildly elevated SGPT and should I be worried?
SGPT up to 1–2 times the upper limit of normal (e.g., 60–100 IU/L) is "mildly elevated" and is very common. Common causes include fatty liver, recent viral illness, vigorous exercise, certain medications, and alcohol. A single mildly elevated result should be repeated in 4–6 weeks. If it persists, further evaluation (ultrasound abdomen, hepatitis B/C screening) is warranted. SGPT > 3× upper limit of normal (> 150–180 IU/L) requires urgent evaluation.
Q: Does the LFT test require fasting?
An 8-hour fast improves the accuracy of bilirubin measurements and is generally preferred. Most liver enzyme values (SGPT, SGOT, ALP, GGT) are not significantly affected by recent food intake. However, for consistent serial monitoring, test under the same conditions each time. Avoid alcohol for at least 48 hours before the test — alcohol can acutely elevate GGT and SGOT.
Q: Are herbal and ayurvedic medicines safe for the liver?
Some herbal preparations are safe; others have well-documented hepatotoxicity. Studies from AIIMS and ILBS have identified liver damage from certain patent Ayurvedic formulations containing heavy metals (mercury, lead), herbs like kava, and some preparations used for weight loss or joint pain. If you are taking any herbal or OTC supplement, inform your doctor and include it in your medication list before any LFT check-up.
Q: How do I know if I have fatty liver?
An LFT showing mildly elevated SGPT (ALT) in the context of obesity, diabetes, or metabolic syndrome is a common first clue. However, LFT can be completely normal in up to 70% of people with fatty liver (NAFLD). The gold standard for diagnosis is an ultrasound abdomen, which detects fatty infiltration of the liver visually. FibroScan (liver stiffness measurement) is increasingly used to assess severity without biopsy.
Q: Can I donate blood if my SGPT is elevated?
No. Blood banks in India follow NBTC (National Blood Transfusion Council) guidelines that disqualify donors with SGPT > 40–45 IU/L. This is because elevated liver enzymes may indicate hepatitis B, hepatitis C, or other infections. If you are deferred at blood donation due to elevated SGPT, consult a doctor for evaluation.
Q: Is LFT affected by exercise?
SGOT (AST) can be transiently elevated by vigorous exercise — particularly after intense gym workouts, long-distance running, or heavy lifting — because AST is also present in muscle. SGPT (ALT) is less affected by exercise. If you exercise regularly and your SGOT is mildly elevated but SGPT is normal, muscle-related elevation is likely. A CK (Creatine Kinase) test can help distinguish liver vs muscle as the source.
Q: How often should I get an LFT if I have hepatitis B?
For chronic Hepatitis B carriers, the Indian National Association for Study of the Liver (INASL) recommends monitoring LFT every 6 months, along with a hepatitis B viral load (HBV DNA) test. Patients on antiviral treatment for Hepatitis B need LFT monitoring every 3 months. An annual ultrasound and AFP (alpha-fetoprotein) for liver cancer screening is also recommended.
References
- Institute of Liver and Biliary Sciences (ILBS), New Delhi. Guidelines on Non-Alcoholic Fatty Liver Disease in India. https://www.ilbs.in/guidelines/nafld
- Indian National Association for Study of the Liver. INASL Guidelines on Hepatitis B. https://www.inasl.net/guidelines_hepatitisb.html
- World Health Organization. Global Hepatitis Report 2024. https://www.who.int/publications/i/item/global-hepatitis-report-2024
